Developing an outcome measure for excessive saliva management in MND and an evaluation of saliva burden in Sheffield

References

• Leigh PN, Ray-Chaudhuri K. Motor neuron disease. J Neurol Neurosurg Psychiatry. 1994;57:886–96.
   PubMed Web of Science ®Google Scholar
• Talbot K. Motor neuron disease: the bare essentials. Pract Neurol. 2009;9:303–9.
   PubMedGoogle Scholar
• Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942–55.
   PubMed Web of Science ®Google Scholar
• Hobson EV, McGeachan A, Al-Chalabi A, Chandran S, Crawley F, Dick D, et al. Management of sialorrhoea in motor neuron disease: a survey of current UK practice. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:521–7.
   PubMed Web of Science ®Google Scholar
• Young CA, Ellis C, Johnson J, Sathasivam S, Pih N. Treatment for sialorrhoea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis. Cochrane Database Syst Rev 2011:CD006981.
   Google Scholar
• Guy N, Bourry N, Dallel R, Dualé C, Verrelle P, Lapeyre M, et al. Comparison of radiotherapy types in the treatment of sialorrhoea in amyotrophic lateral sclerosis. Journal of Palliative Medicine. 2011;14:391–5.
   PubMed Web of Science ®Google Scholar
• Hockstein NG, Samadi DS, Gendron K, Handler SD. Sialorrhoea: a management challenge. Am Fam Physician. 2004;69:2628–34.
   PubMed Web of Science ®Google Scholar
• Newall AR, Orser R, Hunt M. The control of oral secretions in bulbar ALS/MND. Journal of the Neurological Sciences. 1996;139:43–4.
   PubMed Web of Science ®Google Scholar
• Guidubaldi A, Fasano A, Ialongo T, Piano C, Pompili M, Mascianà R, et al. Botulinum toxin A versus B in sialorrhoea: a prospective, randomized, double-blind, cross-over pilot study in patients with amyotrophic lateral sclerosis or Parkinson’s disease. Movement Disord. 2011;26:313–9.
   PubMed Web of Science ®Google Scholar
• Suskind DL, Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhoea in children with cerebral palsy. Laryngoscope. 2002;112:73–81.
   PubMed Web of Science ®Google Scholar
• Perez Lloret S, Piran Arce G, Rossi M, Caivano Nemet ML, Salsamendi P, Merello M. Validation of a new scale for the evaluation of sialorrhoea in patients with Parkinson’s disease. Mov Disord. 2007;22:107–11.
   PubMed Web of Science ®Google Scholar
• Jackson CE, Gronseth G, Rosenfeld J, Barohn RJ, Dubinsky R, Simpson CB, et al. Randomized double-blind study of botulinum toxin type B for sialorrhoea in ALS patients. Muscle Nerve. 2009;39:137–43.
   PubMed Web of Science ®Google Scholar
• Abdelnour-Mallet M, Tezenas Du Montcel S, Cazzolli PA, Assouline A, Pointon C, Leveque N, et al. Validation of robust tools to measure sialorrhoea in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;14:307–7.
   Google Scholar
• Cooper-Knock J, Ahmedzai SH, Shaw PJ. The use of subcutaneous glycopyrrolate in the management of sialorrhoea and facilitating the use of non-invasive ventilation in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:464–5.
   PubMed Web of Science ®Google Scholar
• Giess R, Naumann M, Werner E, Riemann R, Beck M, Puls I, et al. Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2000; 69:121–3.
   PubMed Web of Science ®Google Scholar
• Campbell MJ, Machin D, Walters SJ. Medical Statistics : a textbook for the health sciences. 4th edn. Chichester: Wiley, 2007.
   Google Scholar
• Bland JM, Altman DG. Cronbach’s alpha. Br Med J. 1997;314:572.
   PubMed Web of Science ®Google Scholar
• Fayers PM, Machin D. Quality of life : the assessment, analysis and interpretation of patient reported outcomes. 2nd edn. Chichester: Wiley; 2007.
   Google Scholar
• Veis S. Salivary flow in persons with ALS (poster). 11th International Symposium on ALS/MND, Aarhus, Denmark, 2000.
   Google Scholar
• Dand P, Sakel M. The management of drooling in motor neuron disease. International Journal of Palliative Nursing. 2010;16:560–4.
   Google Scholar
• Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomized controlled trial. Lancet Neurol. 2006;5:140–7.
   PubMed Web of Science ®Google Scholar
• Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. The New England Journal of Medicine. 2001;344: 1688–700.
   PubMed Web of Science ®Google Scholar
• Peysson S, Vandenberghe N, Philit F, Vial C, Petitjean T, Bouhour F, et al. Factors predicting survival following non-invasive ventilation in amyotrophic lateral sclerosis. Eur Neurol. 2008;59:164–71.
   PubMed Web of Science ®Google Scholar
• Peacock J, Peacock PJ. Oxford Handbook of Medical Statistics. Oxford: Oxford University Press; 2011.
   Google Scholar